Artiva Biotherapeutics, Inc. ARTV Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Artiva Biotherapeutics, Inc.’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →
Ask your AI about Artiva Biotherapeutics, Inc.'s change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Artiva Biotherapeutics, Inc.'s change in AR?
- Artiva Biotherapeutics, Inc. (ARTV) reported change in AR of -$0 in Q4 2025.
- How has Artiva Biotherapeutics, Inc.'s change in AR changed year-over-year?
- Artiva Biotherapeutics, Inc.'s change in AR increased by 100.0% year-over-year, from -$569K to -$0.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s change in AR?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s change in AR has grown at a -100.0% compound annual growth rate (CAGR), from $510K to $0.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.